Authors:
Symons, MCR
Rusakiewicz, S
Rees, RC
Ahmad, SI
Citation: Mcr. Symons et al., Hydrogen peroxide: a potent cytotoxic agent effective in causing cellular damage and used in the possible treatment for certain tumours, MED HYPOTH, 57(1), 2001, pp. 56-58
Authors:
Clark, RE
Dodi, IA
Hill, SC
Lill, JR
Aubert, G
Macintyre, AR
Rojas, J
Bourdon, A
Bonner, PLR
Wang, LH
Christmas, SE
Travers, PJ
Creaser, CS
Rees, RC
Madrigal, JA
Citation: Re. Clark et al., Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein, BLOOD, 98(10), 2001, pp. 2887-2893
Authors:
McArdle, SEB
Rees, RC
Mulcahy, KA
Saba, J
McIntyre, CA
Murray, AK
Citation: Seb. Mcardle et al., Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant, CANCER IMMU, 49(8), 2000, pp. 417-425
Authors:
Ali, SA
McLean, CS
Boursnell, MEG
Martin, G
Holmes, CL
Reeder, S
Entwisle, C
Blakeley, DM
Shields, JG
Todryk, S
Vile, R
Robins, RA
Rees, RC
Citation: Sa. Ali et al., Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes, CANCER RES, 60(6), 2000, pp. 1663-1670
Authors:
Ali, SA
Rees, RC
Anderson, DQ
Reed, MWR
Goepel, JR
Brown, NJ
Citation: Sa. Ali et al., Trafficking of 'immune' CD4(+)/CD8(+) T-lymphocytes into the RENCA tumour microcirculation in vivo in mice, BR J CANC, 83(8), 2000, pp. 1061-1068
Authors:
Sisley, K
Parsons, MA
Garnham, J
Potter, AM
Curtis, D
Rees, RC
Rennie, IG
Citation: K. Sisley et al., Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma, BR J CANC, 82(2), 2000, pp. 330-338
Authors:
Creaser, CS
Lill, JR
Bonner, PLR
Hill, SC
Rees, RC
Citation: Cs. Creaser et al., Nano-electrospray and microbore liquid chromatography-ion trap mass spectrometry studies of copper complexation with MHC restricted peptides, ANALYST, 125(4), 2000, pp. 599-603
Authors:
Palmer, K
Moore, J
Everard, M
Harris, JD
Rodgers, S
Rees, RC
Murray, AK
Mascari, R
Kirkwood, J
Riches, PG
Fisher, C
Thomas, JM
Harries, M
Johnston, SRD
Collins, MKL
Gore, ME
Citation: K. Palmer et al., Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma, HUM GENE TH, 10(8), 1999, pp. 1261-1268
Citation: Rc. Rees et S. Mian, Selective MHC expression in tumours modulates adaptive and innate antitumour responses, CANCER IMMU, 48(7), 1999, pp. 374-381
Authors:
Prest, SJ
Rees, RC
Murdoch, C
Marshall, JF
Cooper, PA
Bibby, M
Li, G
Ali, SA
Citation: Sj. Prest et al., Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: Subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials, CLIN EXP M, 17(5), 1999, pp. 389-396
Authors:
Geng, L
Ali, SA
Marshall, JF
Mackay, CL
Hart, IR
Delcommence, M
Streuli, CH
Rees, RC
Citation: L. Geng et al., Fibronectin is chemotactic for CT26 colon carcinoma cells: sub-lines selected for increased chemotaxis to fibronectin display decreased tumorigenicity and lung colonization, CLIN EXP M, 16(8), 1998, pp. 683-691